Description: Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. It primarily focuses on the development, testing, and commercialization of its active transdermal patch, called the U-Strip, that has been designed to facilitate the needle-free delivery of drugs with large molecular structures, such as Insulin into the bloodstream. The company was formerly known as Second Stage Ventures, Inc. and changed its name to Dermisonics, Inc. in October 2004. Dermisonics, Inc. was founded in 2000 and is based in Irvine, California.
2 Park Plaza
Irvine,
CA
92614
United States
Phone:
949-733-1101
Officers
| Name | Title |
|---|---|
| Mr. Bruce H. Haglund | Executive Chairman, Acting Principal Exec.,Financial & Accounting Officer |
Exchange: OTCCE
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | September |
| Full Time Employees: | 0 |